Mary E. Norton MD
Birth Defect & Fetal Treatment, Maternal & Fetal Medicine/High Risk, Reproductive Genetics/Prenatal Genetics
University of California, San Francisco
Join to View Full Profile
1825 4th StSan Francisco, CA 94143
Phone+1 415-476-4080
Dr. Norton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterResidency, Obstetrics and Gynecology, 1986 - 1990
University of Washington School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1990 - 2025
MA State Medical License 1988 - 1998
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Clinical Trials
- Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL Start of enrollment: 2024 Oct 18
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Fetal MRI Findings, Etiology, and Outcome in Prenatally Diagnosed Schizencephaly.Elizabeth George, Rachel Vassar, Yolanda Yu, Mary E Norton, Dawn Gano
AJNR. American Journal of Neuroradiology. 2025-04-02 - Fetal malformations of cortical development: review and clinical guidance.Jeffrey B Russ, Sonika Agarwal, Charu Venkatesan, Barbara Scelsa, Brigitte Vollmer
Brain. 2025-03-06 - Best Practice & Research clinical obstetrics & gynaecology.Kate Swanson, Mary E Norton
Best Practice & Research. Clinical Obstetrics & Gynaecology. 2025-02-01
Press Mentions
Experts: Don't Say 'Heartbeat' to Describe Ultrasound Findings in Early PregnancyAugust 29th, 2024- SRU Develops New Lexicon for Ultrasound Findings in Pregnant WomenAugust 27th, 2024
- Landmark SMART Study Demonstrates High Accuracy of Natera’s Panorama® NIPT for 22q11.2 Deletion ScreeningJanuary 20th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
